Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
POINT Biopharma Global (PNT)
NASDAQ:PNT
RESEARCH TOOLSreports
Holding PNT?
Track your performance easily
See the Price Targets and Ratings of:
PNT Analyst Ratings
Hold
0 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PNT Stock 12 Month Forecast
Average Price Target
$12.50
▲(0.00% Upside)
| Highest Price Target$12.50 | Average Price Target$12.50 | Lowest Price Target$12.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Brookline Capital Markets
Downgraded
12/20/23
Leerink Partners
Reiterated
12/18/23
Truist Financial
Reiterated
11/28/23
Piper Sandler
Reiterated
11/14/23
Raymond James
Downgraded
10/05/23
William Blair
Downgraded
10/04/23
Jefferies
Downgraded
10/03/23
Oppenheimer
Reiterated
05/16/23
Berenberg Bank
$16
Buy
28.00%
Upside
Reiterated
05/16/23
Berenberg Bank Sticks to Their Buy Rating for POINT Biopharma Global (PNT)
―
Guggenheim
―
Hold
―
Downgraded
10/04/23
Point Biopharma downgraded to Neutral from Buy at GuggenheimPoint Biopharma downgraded to Neutral from Buy at Guggenheim
Best Analysts Covering POINT Biopharma Global
Which Analyst Should I Follow If I Want to Buy PNT and Sell After:
1 Month
xxx
Success Rate
2/4 ratings generated profit
Average Return
+0.05%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +0.05% per trade.
3 Months
xxx
Success Rate
2/4 ratings generated profit
Average Return
-0.68%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -0.68% per trade.
1 Year
Success Rate
3/4 ratings generated profit
Average Return
+50.68%
reiterated a buy rating 2 years ago
Copying Zhiqiang Shu's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +50.68% per trade.
2 Years
xxx
Success Rate
4/4 ratings generated profit
Average Return
+60.98%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +60.98% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PNT Analyst Recommendation Trends
Rating
Aug 23
Sep 23
Oct 23
Nov 23
Dec 23
Strong Buy
8
8
7
2
0
Buy
1
0
0
1
1
Hold
0
0
12
15
19
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
8
19
18
20
Each month's total comprises the sum of three months' worth of ratings.
PNT Financial Forecast
PNT Stock Forecast FAQ
What is PNT’s average 12-month price target, according to analysts?
Based on analyst ratings, POINT Biopharma Global’s 12-month average price target is $12.50.
What is PNT’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for PNT, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PNT a Buy, Sell or Hold?
POINT Biopharma Global has a consensus rating of Hold which is based on 0 buy ratings, 8 hold ratings and 0 sell ratings.
What is POINT Biopharma Global’s price target?
The average price target for POINT Biopharma Global is $12.50. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.50 ,the lowest forecast is $12.50. The average price target represents 0.00% Increase from the current price of $12.5.
The highest analyst price target is $12.50 ,the lowest forecast is $12.50. The average price target represents 0.00% Increase from the current price of $12.5.
What do analysts say about POINT Biopharma Global?
POINT Biopharma Global’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of PNT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.